![Feature image Oslo University Hospital](https://www.fatetherapeutics.com/wp-content/uploads/2017/06/Oslo-University-Hospital.jpg)
We are conducting a research collaboration with Oslo University Hospital led by Dr. Karl-Johan Malmberg, a leading expert in NK cell biology and killer cell immunoglobulin-like receptors. Our specific goals of this collaboration are to identify NK cell modifications that promote persistence and enhanced anti-tumor potency, and to create new iPSC-derived NK cell product candidates for development.